Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts

[1]  C. de Beer,et al.  The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay , 2008, Virology Journal.

[2]  C. de Beer,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Activity by Purified Human Breast Milk Mucin (MUC1) in an Inhibition Assay , 2007, Neonatology.

[3]  G. Kotwal,et al.  Antiviral Activity of Purified Human Breast Milk Mucin , 2007, Neonatology.

[4]  C. de Beer,et al.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay , 2006, Virology Journal.

[5]  S. Fisher,et al.  Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori. , 2005, Biochemistry.

[6]  L. Bobek,et al.  Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity. , 2003, The Biochemical journal.

[7]  L. K. Rasmussen,et al.  Purification of MUC1 from bovine milk-fat globules and characterization of a corresponding full-length cDNA clone. , 2001, Journal of dairy science.

[8]  L. Bobek,et al.  In Vitro Assessment of Antifungal Therapeutic Potential of Salivary Histatin-5, Two Variants of Histatin-5, and Salivary Mucin (MUC7) Domain 1 , 2000, Antimicrobial Agents and Chemotherapy.

[9]  E. D. de Geus,et al.  Salivary MUC5B-Mediated Adherence (Ex Vivo) of Helicobacter pylori During Acute Stress , 2000, Psychosomatic medicine.

[10]  C. Corbett,et al.  HIV infection in adults: a therapeutic update. , 1999, The American journal of managed care.

[11]  J. Hoxie,et al.  Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. , 1999, AIDS research and human retroviruses.

[12]  S. Fisher,et al.  Separate oligosaccharide determinants mediate interactions of the low-molecular-weight salivary mucin with neutrophils and bacteria. , 1999, Biochemistry.

[13]  B. Liu,et al.  Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria. , 1999, Archives of biochemistry and biophysics.

[14]  M. Levine,et al.  Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1. , 1999, Biochimica et biophysica acta.

[15]  H. Friedman,et al.  Submandibular Salivary Proteases: Lack of a Role in Anti-HIV Activity , 1998, Journal of dental research.

[16]  A. Burlingame,et al.  Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity. , 1998, Biochemistry.

[17]  R. Silverstein,et al.  Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva , 1998, The Journal of experimental medicine.

[18]  S. Ho,et al.  Immunohistochemical detection of gastric mucin in normal and disease states. , 1998, Oncology research.

[19]  H. Friedman,et al.  Human submandibular saliva specifically inhibits HIV type 1. , 1997, AIDS research and human retroviruses.

[20]  J. Orenstein,et al.  AIDS-associated infections in salivary glands: autopsy survey of 60 cases. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Gendler,et al.  The epithelial mucin, MUC1, of milk, mammary gland and other tissues. , 1995, Biochimica et biophysica acta.

[22]  D. Verwoerd,et al.  Distinct populations of high-M(r) mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis. , 1995, The Biochemical journal.

[23]  D. Thornton,et al.  Methods for separation and deglycosylation of mucin subunits. , 1995, Analytical biochemistry.

[24]  L. Epstein,et al.  Interaction of HIV-1 and human salivary mucins. , 1994, Journal of acquired immune deficiency syndromes.

[25]  S. Baron,et al.  HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation. , 1993, Journal of the American Dental Association.

[26]  R. Steigbigel,et al.  Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. , 1992, Journal of acquired immune deficiency syndromes.

[27]  D. J. Strydom,et al.  Amino acid analysis utilizing phenylisothiocyanate derivatives. , 1988, Analytical biochemistry.

[28]  M. Gonda,et al.  Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. , 1987, AIDS research and human retroviruses.

[29]  A. Allen,et al.  A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain [proceedings]. , 1978, Biochemical Society transactions.

[30]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[31]  J. M. Creeth,et al.  Density gradient equilibrium methods applied to blood‐group specific glycoproteins , 1970, FEBS letters.

[32]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.